Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Aug 26, 2025 06:30AM Shattuck Labs closes $103 million private placement, adds board members
Aug 26, 2025 06:30AM Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
Aug 15, 2025 05:28PM Form SCHEDULE 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 06:07PM Form SCHEDULE 13G CytomX Therapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 06:03PM Form SCHEDULE 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 06:00PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 05:56PM Form SCHEDULE 13G/A Verastem, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 05:53PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 04:40PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 13, 2025 07:44PM Form SCHEDULE 13D/A ArriVent BioPharma, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 12, 2025 05:22PM Form 4 Turnstone Biologics Corp For: Aug 08 Filed by: ORBIMED ADVISORS LLC
Jul 30, 2025 09:30PM Form 4 ImageneBio, Inc. For: Jul 25 Filed by: ORBIMED ADVISORS LLC
Jul 30, 2025 09:28PM Form SCHEDULE 13D/A ImageneBio, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 24, 2025 05:45PM Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 21, 2025 05:33PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 21, 2025 05:28PM Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 15, 2025 08:18PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 9, 2025 08:06PM Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 7, 2025 06:02PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 1, 2025 09:24PM Form 4 Corvus Pharmaceuticals, For: Jun 27 Filed by: ORBIMED ADVISORS LLC
Jun 26, 2025 05:10PM Form 4 Passage BIO, Inc. For: Jun 24 Filed by: ORBIMED ADVISORS LLC
Jun 24, 2025 06:49PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 18, 2025 08:23PM Form SCHEDULE 13D/A Ikena Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 17, 2025 05:30PM Form SCHEDULE 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
May 16, 2025 05:26PM Form 4 NeuroPace Inc For: May 14 Filed by: ORBIMED ADVISORS LLC
May 15, 2025 08:16PM Form SCHEDULE 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
May 15, 2025 08:13PM Form SCHEDULE 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
May 15, 2025 08:09PM Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
May 15, 2025 06:46PM Form SCHEDULE 13G Whitehawk Therapeutics, Filed by: ORBIMED ADVISORS LLC
May 15, 2025 06:41PM Form SCHEDULE 13G/A Verastem, Inc. Filed by: ORBIMED ADVISORS LLC
May 15, 2025 04:19PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 14, 2025 08:49PM Form SCHEDULE 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
May 12, 2025 07:13PM Form SCHEDULE 13D/A Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
May 12, 2025 04:05PM Xtant Medical Reports First Quarter 2025 Financial Results
May 1, 2025 09:21PM Form SCHEDULE 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Apr 25, 2025 07:48PM Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 24, 2025 05:39PM Form 4 Passage BIO, Inc. For: Apr 24 Filed by: ORBIMED ADVISORS LLC
Apr 17, 2025 06:11PM Form 4 Passage BIO, Inc. For: Apr 15 Filed by: ORBIMED ADVISORS LLC
Apr 16, 2025 08:05AM Xtant Medical Holdings (XTNT) Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Apr 16, 2025 08:05AM Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Apr 15, 2025 05:40PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 14, 2025 07:15PM Form 4 Xtant Medical Holdings, For: Apr 10 Filed by: ORBIMED ADVISORS LLC
Apr 14, 2025 07:10PM Form SCHEDULE 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Apr 11, 2025 07:21PM Form SCHEDULE 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 9, 2025 06:59PM Form 144 Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 4, 2025 12:11PM RayThera Raises $110 Million in Series A Financing
Mar 28, 2025 04:30PM Traws Pharma (TRAW) Announces Management Updates
Mar 28, 2025 04:30PM Traws Pharma Announces Management Updates
Mar 21, 2025 08:00PM Form 4 Disc Medicine, Inc. For: Mar 19 Filed by: ORBIMED ADVISORS LLC
Mar 20, 2025 11:06AM Heng Ren Partners Demands Sinovac (SVA) Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed